EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY 4.0

Latest Update on lncRNA in Epithelial Ovarian Cancer—A Scoping Review

Katarzyna Kwas, Maria Szubert iD, Jacek Radosław Wilczyński iD

Cells · 2025

DOI: 10.3390/cells14070555 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Cells, 2025. Verfasst von Katarzyna Kwas und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical and Oncologic Gynaecology, 1st Department of Gynaecology and Obstetrics, Medical University of Lodz, 90-136 Łódź, Poland. Hauptthemen laut MEDLINE: Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, RNA, Long Noncoding. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 321 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Long noncoding RNAs (lncRNAs) are RNA molecules exceeding 200 nucleotides that do not encode proteins yet play critical roles in regulating gene expression at multiple levels, such as chromatin modification and transcription. These molecules are significantly engaged in cancer progression, development, metastasis, and chemoresistance. However, the function of lncRNAs in epithelial ovarian cancer (EOC) has not yet been thoroughly studied. EOC remains challenging due to its complex molecular pathogenesis, characterized by genetic and epigenetic alterations. Emerging evidence suggests that lncRNAs, such as XIST, H19, NEAT1, and MALAT1, are involved in EOC by modulating gene expression and signaling pathways, influencing processes like cell proliferation, invasion, migration, and chemoresistance. Despite extensive research, the precise mechanism of acting of lncRNAs in EOC pathogenesis and treatment resistance still needs to be fully understood, highlighting the need for further studies. This review aims to provide an updated overview of the current understanding of lncRNAs in EOC, emphasizing their potential as biomarkers and therapeutic targets. We point out the gaps in the knowledge regarding lncRNAs’ influence on epithelial ovarian cancer (EOC), deliberating on new possible research areas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Ovarian EpithelialOvarian NeoplasmsRNA, Long NoncodingFemaleHumansBiomarkers, TumorCell ProliferationGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

epithelial ovarian cancerlong noncoding RNAmolecular pathogenesis

Substanzen

Biomarkers, TumorRNA, Long Noncoding

Autor:innen und Institutionen

  • Department of Surgical and Oncologic Gynaecology, 1st Department of Gynaecology and Obstetrics, Medical University of Lodz, 90-136 Łódź, Poland.

ORCID-Profile: Maria Szubert, Jacek Radosław Wilczyński

Zitieren

APA

Kwas, K., Szubert, M., & Wilczyński, J. R. (2025). Latest Update on lncRNA in Epithelial Ovarian Cancer—A Scoping Review. Cells. https://doi.org/10.3390/cells14070555

Vancouver

Kwas K, Szubert M, Wilczyński JR. Latest Update on lncRNA in Epithelial Ovarian Cancer—A Scoping Review. Cells. 2025. doi:10.3390/cells14070555

BibTeX
@article{Kwas2025,
  author = {Kwas, Katarzyna and Szubert, Maria and Wilczyński, Jacek Radosław},
  title = {Latest Update on lncRNA in Epithelial Ovarian Cancer—A Scoping Review},
  journal = {Cells},
  year = {2025},
  doi = {10.3390/cells14070555}
}
Kostenlos starten →